1. | fillyphan83 | |
2. | tyldesley4554 | |
3. | schoendev | |
4. | stephanemarquis | |
5. | polliaymeri9 |
1. | fillyphan83 | |
2. | tyldesley4554 | |
3. | schoendev | |
4. | stephanemarquis | |
5. | polliaymeri9 |
1. | tyldesley4554 03/01/2018 Asterias Provides Update for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury |
2. | tyldesley4554 02/22/2018 when it fills in the gap |
3. | fillyphan83 02/22/2018 Man you guys missed this 8.5 gain lol |
4. | fillyphan83 02/15/2018 Asterias Expands Global IP Portfolio with New Patents, Including Key Additional Patent Protection for its Cancer Immunotherapy Program |
5. | fillyphan83 06/13/2018 Asterias Biotherapeutics Announces First Patient Dosed in First-in-Human Clinical Study of Immunotherapy AST-VAC2 in Non-Small Cell Lung Cancer |